BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, July 16, 2026
Home » SARS-CoV-2

Articles Tagged with ''SARS-CoV-2''

Other news to note for April 1, 2021

April 1, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aditx Therapeutics, Collection Sites, Concert Genetics, Corvida Medical, Dalrada, Dedalus, Dx Medical Solutions, Dxc Technology, Egenesis, Euroimmun, Fresenius Kabi, Genematters, Guardant Health, Health Clinics, Invitae, Lifestance Health, Medivolve, Meridian Bioscience, Myomo, Ontrak, Pear Therapeutics, Perkinelmer, Premier, Prescryptive Health, Sqi Diagnostics, Stagezero Life Sciences.
Read More
Earth threatened by virus

Global cases rise, but more weapons advance to combat COVID-19

April 1, 2021
By Karen Carey
As COVID-19 vaccinations continue to roll out, momentum builds with strong phase III data for what could become the fourth and fifth walls of defense in the U.S.
Read More

Other news to note for March 31, 2021

March 31, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief:, Agilent Technologies, Alydia, B. Braun, Delfi Diagnostics, Infraredx, Janssen, Komodo Health, Merck, Natera, Nipro, Organon, Oscar A-Co, Premier, Takeda, Tempus, Tesis Labs.
Read More

Regulatory front for March 31, 2021

March 31, 2021
By Holland Johnson
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: FDA warns about differing complication rates for acellular dermal matrix; CDC and NIH initiate COVID-19 self-testing pilot program; GHIT invests $21M; MHRA updates guidance.
Read More

Regulatory actions for March 30, 2021

March 30, 2021
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Becton Dickinson, Binx Health, Gold Standard Diagnostics, Nines.
Read More

Other news to note for March 30, 2021

March 30, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: AI/ML Innovations, Aspect Biosystems, Beigene, Biomax Informatics, Djo Global, Genial Light, Ginkgo Bioworks, Guardant Health, Henry Schein, Hisense, IBH, Insight Medical Systems, Lantheus Holdings, JSR, Mapkure, Materials and Machines, Mimedx, Noria Therapeutics, Olive Labs, Orasure Technologies, Origo, Osang Healthcare, Personalis, Premier, Proscia, Recuro Health, Sciex, Seer, Stradis Medical, Strategic Solutions Group, Teladoc, Texcell, Think Research, Todos Medical, Toyoda Gosei, Trinity Biotech, Unilabs, Uprise, Zi Medical.
Read More
Aerosolsense Sampler in waiting room

Thermo Fisher launches SARS-CoV-2 ambient air surveillance system

March 29, 2021
By Mary Ellen Schneider
Thermo Fisher Scientific Inc. has launched a surveillance system that can detect SARS-CoV-2 in ambient air in indoor spaces, providing a potential complement to individual testing and other COVID-19 safety protocols. The system, called the Aerosolsense Sampler, works by capturing a sample of the ambient air on a cartridge using Thermo Fisher’s collection substrate.
Read More
Antibodies block virus from cell

EU sets guidelines for COVID rapid antibody tests

March 29, 2021
By Nuala Moran
LONDON – Getting a handle on the specificity and sensitivity of rapid COVID-19 antibody tests, how they compare to each other and how they should be applied in population screening to understand who has had the virus and how it has spread, has been a source of difficulty and dispute between manufacturers, clinicians and public health experts.
Read More

Regulatory actions for March 29, 2021

March 29, 2021
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Helius Medical Technologies, Medtronic, Qiagen, STS Lab.
Read More

Other news to note for March 29, 2021

March 29, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aurora Spine, Batm, Bracco Diagnostics, Cardionavix, Casamba, Coloplast, Escher Biomedical Diagnostics, Health Logic Interactive, Hitachi, Hoya, Lumendi, Meso Scale Diagnostics, Net Health Systems, Orbita, Philips, Vizient.
Read More
Previous 1 2 … 56 57 58 59 60 61 62 63 64 … 136 137 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 16, 2026.
  • AI-generated  illustration of a neuron with tau protein aggregation

    AAIC 2026: Age of amyloid is being joined by time of tau

    BioWorld
    The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
  • Senior medical exam

    Celia trial: data strong, analysts skeptical

    BioWorld
    Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 14, 2026
  • Illustration of T cells attacking cancer

    GABA signaling linked to immune resistance in some tumors

    BioWorld
    Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing